Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Pediatric Research|May 1, 1989
Alterations of pancreatic growth and of GP-2 content in the reserpinized rat model of cystic fibrosisF A Leblond, J Morisset, D LeBelThe Biochemical Journal|August 1, 1991
In resting conditions, the pancreatic granule membrane protein GP-2 is secreted by cleavage of its glycosylphosphatidylinositol anchorE Paul, F A Leblond, D LeBelFEBS Letters|July 31, 1998
Peroxynitrite production by human neutrophils, monocytes and lymphocytes challenged with lipopolysaccharideC Gagnon, F A Leblond, J G FilepBiomaterials|November 1, 1996
Quantitative method for the evaluation of biomicrocapsule resistance to mechanical stressF A Leblond, J Tessier, J P HalléThe Biochemical Journal|April 1, 1993
Reconstitution in vitro of the pH-dependent aggregation of pancreatic zymogens en route to the secretory granule: implication of GP-2F A Leblond, G Viau, J Lainé, et al.Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|May 1, 1986
Reducing conditions induce a total degradation of the major zymogen granule membrane protein in both its membranous and its soluble form. Immunochemical quantitation of the two formsJ Paquette, F A Leblond, M Beattie, et al.Pediatric Research|May 1, 1989
Light and electron microscopy of the exocrine pancreas in the chronically reserpinized ratG Grondin, F A Leblond, J Morisset, et al.Clinical Pharmacology and Therapeutics|April 5, 2008
Emerging evidence of the impact of kidney disease on drug metabolism and transportT D Nolin, J Naud, F A Leblond, et al.Journal of Immunological Methods|November 13, 1989
A competition enzyme-linked immunosorbent assay (ELISA) for the measurement of pancreatic GP-2 glycoproteinF A Leblond, B G Talbot, I Lauzon, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2000
Decreased in vivo metabolism of drugs in chronic renal failureF A Leblond, L Giroux, J P Villeneuve, et al.Pageof 2